MYCN and metastatic neoplasm: Similarly, another study showed that aberrant methylation of the PCDHB family members is associated with other clinical factors that indicate poor clinical outcome, such as MYCN amplification, metastatic tumor stage, and older age of the patient at the time of diagnosis [50].